FINWIRES · TerminalLIVE
FINWIRES

Kenvue's Tylenol With Naproxen Combination Tablet Gets FDA Approval for Pain Relief

By

Kenvue's (KVUE) Kenvue Brands unit received approval for its Tylenol with Naproxen combination tablet to provide up to 12 hours of pain relief in adults and children 12 years and older, the US Food and Drug Administration said Friday.

The nonprescription combination product is indicated for temporary relief of minor aches and pains due to headache, backache, muscular aches, toothache, menstrual cramps, and minor arthritis pain, the FDA said.

The agency said the approval was supported by data showing the effectiveness and safety of the combination drug.

Kenvue shares were up about 1.1% in Friday trading.

Price: $19.11, Change: $+0.21, Percent Change: +1.08%

Related Articles

Wire

Business First Bancshares Q2 Earnings, Revenue Rise; Shares Drop After Hours

Business First Bancshares (BFST) reported core Q2 earnings late Thursday of $0.71 per diluted share, up from $0.66 a year earlier.Analysts polled by FactSet expected $0.70.Revenue in the three months ended June 30, expressed as net interest income plus total other income, rose to $91.8 million from $81.5 million.Four analysts expected $91.3 million.The company's shares fell 3.3% in after-hours trading.

$BFST
Wire

RingCentral Q2 Adjusted Earnings, Revenue Rise; FY Guidance Increases

RingCentral (RNG) reported Q2 non-GAAP net income late Thursday of $1.22 per diluted share, up from $1.06 a year earlier.Analysts polled by FactSet expected $1.16.Revenue in the three months ended June 30 rose to $657 million from $620 million a year earlier.Analysts expected $650.5 million.RingCentral expects Q3 non-GAAP EPS of $1.25 to $1.30 on revenue of $664 million to $670 million.Analysts expect EPS of $1.25 on revenue of $663.2 million.The company raised full-year non-GAAP EPS guidance to the range of $4.96 to $5.10 on revenue of $2.635 billion to $2.646 billion. The previous forecast was EPS of $4.85 to $5.01 on revenue of $2.62 billion to $2.64 billion.Analysts expect EPS of $4.92 on revenue of $2.63 billion.RingCentral shares rose 1.2% in after-hours trading.

$RNG
Wire

Robert Half Q2 Net Income, Revenue Fall; Shares Drop After Hours

Robert Half (RHI) reported Q2 net income late Thursday of $0.26 per share, down from $0.41 a year earlier.Analysts polled by FactSet expected $0.26.Revenue in the three months ended June 30 fell to $1.34 billion from $1.37 billion a year earlier.Analysts expected $1.32 billion.The company's shares fell 5.3% in after-hours trading.

$RHI